Waseem N, Limketkai BN, Kim B, Woreta T, Gurakar A, Chen Po-Hung

Language: English
References: 31
Page: 119-124
PDF size: 180.98 Kb.

ABSTRACT

Introduction and aim. Critically ill patients in states of circulatory failure are at risk of acute liver injury, from mild elevations in aminotransferases to substantial rises consistent with hypoxic hepatitis or “shock liver”. The present study aims to quantify the national prevalence of acute liver injury in patients with hemodynamic instability, identify risk factors for its development, and determine predictors of mortality. Material and methods. The 2009-2010 Nationwide Inpatient Sample was interrogated using ICD-9-CM codes for hospital admissions involving states of hemodynamic lability. Multivariable logistic regression was used to evaluate the risks of acute liver injury and death in patients with baseline liver disease, congestive heart failure, malnutrition, and HIV. Results. Of the 2,865,446 patients identified in shock, 4.60% were found to have acute liver injury. A significantly greater proportion of patients with underlying liver disease experienced acute liver injury (22.03%) and death (28.47%) as compared to those without liver disease (3.18% and 18.82%, respectively). The odds of developing acute liver injury were increased in all baseline liver diseases studied, including all-cause cirrhosis, hepatitis B, hepatitis C, alcoholic liver disease, and non-alcoholic fatty liver disease, as well as in congestive heart failure and malnutrition. All-cause cirrhosis and alcoholic liver disease, however, conferred the greatest risk. Similar trends were seen with mortality. HIV was not a predictor for acute liver injury. Conclusion. Liver injury is a major concern among patients with protracted circulatory instability, especially those suffering from underlying liver disease, heart failure, or malnutrition.

REFERENCES

1. Brienza N, Dalfino L, Cinnella G, Diele C, Bruno F, Fiore T. Jaundice in critical illness: promoting factors of a concealed reality. Intensive Care Med 2006; 32: 267-74.

2. Kavoliuniene A, Vaitiekiene A, Cesnaite G. Congestive hepatopathy and hypoxic hepatitis in heart failure: a cardiologist's point of view. Int J Cardiol 2013; 166: 554-8.

3. Seeto RK, Fenn B, Rockey DC. Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med 2000; 109: 109-113.

4. Chand N, Sanyal AJ. Sepsis-induced cholestasis. Hepatology 2007; 45: 230-41.

5. Fuhrmann V, Jager B, Zubkova A, Drolz A. Hypoxic hepatitis - epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr 2010; 122: 129-39.

6. Fuchs S, Bogomolski-Yahalom V, Palitel O, Ackerman Z. Ischemic hepatitis. Clinical and laboratory observations of 34 patients. J Clin Gastroenterol 1998; 26: 183-6.

7. Henrion J, Schapira M, Luwaert R, Colin L, Delannoy A, Heller FR. Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine (Baltimore) 2003; 82: 392-406.

8. Birrer R, Takuda Y, Takara T. Hypoxic Hepatopathy: Pathophysiology and Prognosis. Int Med 2007; 46: 1063-70.

9. Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A, Schellongowski, P, et al. Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med 2009; 35: 1397-405.

10. Birrer R, Takuda Y, Takara T. Hypoxic hepatopathy: pathophysiology and prognosis. Intern Med 2007; 46: 1063-70.

11. HCUP NIS Database Documentation. Healthcare Cost and Utilization Project (HCUP). June 2015. Agency for Healthcare Research and Quality, Rockville, MD. Available from: www. hcup-us.ahrq. gov/db/nation/nis/nisdbdocumentation.jsp.

12. Myers RP, Leung Y, Shaheen AA, Li B. Validation of ICD-9- CM/ICD-10 coding algorithms for the identification of patients with acetaminophen overdose and hepatotoxicity using administrative data. BMC Health Serv Res 2007; 7: 159.

13. Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, de Silva HJ, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2009; 3: 269-82.

14. Sarin SK, Kedarisetty CK, Abbas Z, Amarpurkar D, Bihari C, Chan AC, Chawla YK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL) 2014. Hepatol Int 2014; 8: 453-71.

15. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Durand F, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompesnation of cirrhosis. Gastroenterol 2013; 144: 1426-37.

16. Shi Y, Yang Y, Hu Y, Wu W, Yang Q, Zheng M, Zhang S, et al. Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults. Hepatol 2015; 62: 232-42.

17. Henrion J, Colin L, Schmitz A, Schapira M, Heller FR. Ischemic hepatitis in cirrhosis. Rare but lethal. J Clin Gastroenterol 1993; 17: 35-9.

18. Molino G, Avagnina P, Ballare M, Torchio M, Niro AG, Aurucci PE, Grosso M, et al. Combined evaluation of total and functional liver plasma flows and intrahepatic shunting. Dig Dis Sci 1991; 36: 1189-96.

19. Israel Y, Videla L, Bernstein J. Liver hypermetabolic state after chronic ehtanol consumption: hormonal interrelations and pathogenic implications. Fed Proc 1975; 34: 2052-9.

20. Thurman RG, Sungchul JI, Matsumura T, Lemasters JJ. Is hypoxia involved in the mechanism of alcohol-induced liver injury? Fundam Appl Toxicol 1984; 4: 125-33.

21. Wang X, Wu D, Yang L, Gan L, Cederbaum AI. Cytochrome P450 2E1 potentiates ethanol induction of hypoxia and HIF-1 in vivo. Free Radic Biol Med 2013; 63: 175-86.

22. Sharma SK, Saini N, Chwla Y. Hepatitis B virus: inactive carriers. Virol J 2005; 2: 82.

23. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002; 36: S35-S46.

24. Erdogmus B, Tamer A, Buyukkaya R. Portal vein hemodynamics in patients with non-alcoholic fatty liver disease. Tohoku J Exp Med 2008; 215: 89-93.

25. Drolz A, Horvatits T, Michl B, Roedl K, Schellongowski P, Holzinger U, Zauner C, et al. Statin therapy is associated with reduced incidence of hypoxic hepatitis in critically ill patients. J Hepatol 2014; 60: 1187-93.

26. Rautou PE, Cazals-Hatem D, Moreau R, Francoz C, Feldmann G, Lebrec D, Ogier-Denis E, et al. Acute liver cell damage in patients with anorexia nervosa: a possible role of starvationinduced hepatocyte autophagy. Gastroenterol 2008; 135: 840-8.

27. Eliades M, Spyrou E. Vitamin D: a new player in non-alcoholic fatty liver disease? World J Gastroenterol 2015; 21: 1718- 27.

28. Price JC, Seaberg EC, Badri S, Witt MD, D’Acunto K, Thio CL. HIV monoinfection is associated with increased aspartate aminotransferase-to-platelet ratio index, a surrogate marker for hepatic fibrosis. J Infect Dis 2012; 205: 1005-13.

29. Castellares C, Barreiro P, Martin-Carbonero L, Labarga P, Vispo ME, Casado R, Galindo L, et al. Liver cirrhosis in HIVinfected patients: prevalence, aetiology and clinical outcome. J Viral Hepat 2008; 15: 165-72.

30. Thyrault M, Gachot B, Chastang C, Souweine B, Timsit JF, Bedos JP, Regnier B, et al. Septic shock in patients with the acquired immunodeficiency syndrome. Intensive Care Med 1997; 23: 1018-23.

31. D'Ascenzo F, Cerrato E, Biondi-Zoccai G, Moretti C, Omede P, Sciuto F, Bollati M, et al. Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy. Eur Heart J 2011; 33: 875-80.